Trial intelligence / Profile preview

Pregnenolone for Chronic Low Back Pain in OEF/OIF Veterans

NCT01898013Phase 2Completed

Sponsor
Durham VA Health Care System
Start
Sep 2013
Primary completion
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in low back pain (LBP) comparing Pregnenolone with Placebo (2 arms). Primary endpoint: Pain Intensity Rating at 6 weeks. Started Sep 2013; status: completed.

02

Drugs

pregnenolone
03

Conditions

low back pain (LBP)

Beyond the preview

Go deeper on NCT01898013.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01898013.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call